{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:40:27Z","timestamp":1781498427863,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jtct.2023.05.019","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T17:37:55Z","timestamp":1685900275000},"page":"513.e1-513.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["CD3+TCR\u03b1\u03b2\/CD19+-Depleted Mismatched Family or Unrelated Donor Salvage Stem Cell Transplantation for Graft Dysfunction in Inborn Errors of Immunity"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-2265","authenticated-orcid":false,"given":"Subramaniam","family":"Ramanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-029X","authenticated-orcid":false,"given":"Su Han","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6979-9207","authenticated-orcid":false,"given":"Stephen","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5898-993X","authenticated-orcid":false,"given":"Eleri","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-1324","authenticated-orcid":false,"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.05.019_bib0001","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fped.2019.00445","article-title":"Hematopoietic stem cell transplantation for primary immunodeficiencies","volume":"7","author":"Gennery","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2023.05.019_bib0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0003","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.05.019_bib0004","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.05.019_bib0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice","volume":"49","author":"Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0006","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0007","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.exphem.2008.03.018","article-title":"Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor","volume":"36","author":"Taniguchi","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.exphem.2011.05.007","article-title":"Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation","volume":"39","author":"Ikegame","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0009","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2019.03.009","article-title":"Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children","volume":"25","author":"Neven","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0010","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.bbmt.2019.05.013","article-title":"Outcomes of salvage haploidentical transplant with post-transplant cyclophosphamide for rescuing graft failure patients: a report on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy","volume":"25","author":"Prata","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0011","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/s41409-021-01323-9","article-title":"Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders","volume":"56","author":"Albert","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0012","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12185-022-03405-w","article-title":"Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Harada","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0013","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bmt.2013.163","article-title":"Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT","volume":"49","author":"Park","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bjh.14190","article-title":"Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients","volume":"175","author":"Teltschik","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/bloodadvances.2021005628","article-title":"TCR\u03b1\u03b2\/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders","volume":"6","author":"Merli","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.05.019_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41409-022-01883-4","article-title":"Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity","volume":"58","author":"Laberko","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from Hl-A-matched sibling donor,s","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.05.019_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0019","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0020","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/bloodadvances.2021004284","article-title":"Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency","volume":"5","author":"Ramdeny","year":"2021","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.05.019_bib0021","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1182\/blood-2018-99-119792","article-title":"Administration of rimiducid following haploidentical BPX-501 cells in children with malignant or non-malignant disorders who develop graft-versus-host-disease (GVHD)","volume":"132","author":"Elkeky","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.05.019_bib0022","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","article-title":"Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome","volume":"139","author":"Nademi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0023","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2021.04.036","article-title":"International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome","volume":"149","author":"Dimitrova","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0024","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/ACI.0000000000000402","article-title":"Approaches to the removal of T-lymphocytes to minimize graft-versus-host disease in patients with primary immunodeficiencies who do not have a matched sibling donor","volume":"17","author":"Slatter","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10875-022-01239-z","article-title":"TCR\u03b1\u03b2-depleted haploidentical grafts are a safe alternative to HLA-matched unrelated donor stem cell transplants for infants with severe combined immunodeficiency","volume":"42","author":"Tsilifis","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0026","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.05.019_bib0027","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","article-title":"Single-center experience of unrelated and haploidentical stem cell transplantation with TCR\u03b1\u03b2 and CD19 depletion in children with primary immunodeficiency syndromes","volume":"21","author":"Balashov","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.05.019_bib0028","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/bloodadvances.2020004072","article-title":"T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity","volume":"6","author":"Lum","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.05.019_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606930","article-title":"Multicenter outcome of hematopoietic stem cell transplantation for primary immune deficiency disorders in India","volume":"11","author":"Raj","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0030","doi-asserted-by":"crossref","first-page":"26783","DOI":"10.1002\/pbc.26783","article-title":"Reduced-toxicity alternate-donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders","volume":"65","author":"Rastogi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.05.019_bib0031","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10875-019-00600-z","article-title":"Haploidentical stem cell transplantation with post-transplant cyclophosphamide for primary immune deficiency disorders in children: challenges and outcome from a tertiary care center in South India","volume":"39","author":"Uppuluri","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2023.05.019_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.12004","article-title":"T cell depletion in paediatric stem cell transplantation","volume":"172","author":"Booth","year":"2013","journal-title":"Clin Exp Immunol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723013210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723013210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:12Z","timestamp":1763003412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723013210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2666636723013210"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.05.019","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3+TCR\u03b1\u03b2\/CD19+-Depleted Mismatched Family or Unrelated Donor Salvage Stem Cell Transplantation for Graft Dysfunction in Inborn Errors of Immunity","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}